Correlation Between Sanofi ADR and Santen Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sanofi ADR and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sanofi ADR and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sanofi ADR and Santen Pharmaceutical Co, you can compare the effects of market volatilities on Sanofi ADR and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sanofi ADR with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sanofi ADR and Santen Pharmaceutical.

Diversification Opportunities for Sanofi ADR and Santen Pharmaceutical

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Sanofi and Santen is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi ADR and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and Sanofi ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sanofi ADR are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of Sanofi ADR i.e., Sanofi ADR and Santen Pharmaceutical go up and down completely randomly.

Pair Corralation between Sanofi ADR and Santen Pharmaceutical

Considering the 90-day investment horizon Sanofi ADR is expected to generate 2.61 times less return on investment than Santen Pharmaceutical. But when comparing it to its historical volatility, Sanofi ADR is 2.1 times less risky than Santen Pharmaceutical. It trades about 0.02 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  964.00  in Santen Pharmaceutical Co on September 2, 2024 and sell it today you would earn a total of  97.00  from holding Santen Pharmaceutical Co or generate 10.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Sanofi ADR  vs.  Santen Pharmaceutical Co

 Performance 
       Timeline  
Sanofi ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sanofi ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Santen Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Sanofi ADR and Santen Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sanofi ADR and Santen Pharmaceutical

The main advantage of trading using opposite Sanofi ADR and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sanofi ADR position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.
The idea behind Sanofi ADR and Santen Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance